rct
    2019
    High Quality

    Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial (ELFIN)

    ELFIN trial investigators group

    Published in The Lancet

    Key Findings

    Bovine lactoferrin did not reduce late-onset infection, necrotising enterocolitis or mortality in very preterm infants.

    Conclusions

    Large, well-powered trial shows no benefit for routine lactoferrin prophylaxis.

    Limitations

    Single product and dose tested.

    Supplements Studied

    Lactoferrin
    Compound

    Enteral bovine lactoferrin supplementation did not reduce the risk of late-onset infection in very preterm infants.

    Study Details

    Year:2019
    Sample Size:2,203
    Quality Score:10/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.